^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    myStage Dx

    Company:
    Spotlight Medical
    Type:
    CE-IVDR (New IVDR)

    Details

    Evidence
    News
    myStage Dx combines information from a routine H&E slide with standard clinicopathologic variables to assess distant metastasis risk within nine years in adult patients with node-positive, ER-positive, HER2-negative early-stage breast cancer.
    Cancer:
    Breast Cancer
    Gene:
    ER (Estrogen receptor), HER-2 (Human epidermal growth factor receptor 2)
    Method:
    AI-based digital pathology
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    06/23/26
    BC
    HER-2
    CE-IVDR (New IVDR)
    ER